nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—ABCB1—Levothyroxine—hypothyroidism	0.11	0.28	CbGbCtD
Trimipramine—ABCB1—Liothyronine—hypothyroidism	0.11	0.28	CbGbCtD
Trimipramine—ABCB1—Liotrix—hypothyroidism	0.108	0.273	CbGbCtD
Trimipramine—CYP3A4—Levothyroxine—hypothyroidism	0.0661	0.168	CbGbCtD
Trimipramine—Abdominal cramps—Levothyroxine—hypothyroidism	0.0133	0.0366	CcSEcCtD
Trimipramine—Abdominal cramps—Dextrothyroxine—hypothyroidism	0.0133	0.0366	CcSEcCtD
Trimipramine—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0101	0.0278	CcSEcCtD
Trimipramine—Myocardial infarction—Liothyronine—hypothyroidism	0.0101	0.0276	CcSEcCtD
Trimipramine—HTR2A—cerebellar cortex—hypothyroidism	0.00993	0.0658	CbGeAlD
Trimipramine—Abdominal cramps—Liotrix—hypothyroidism	0.00981	0.027	CcSEcCtD
Trimipramine—HTR3A—nerve—hypothyroidism	0.00902	0.0598	CbGeAlD
Trimipramine—CYP2C19—urine—hypothyroidism	0.00826	0.0547	CbGeAlD
Trimipramine—Tingling sensation—Liotrix—hypothyroidism	0.00824	0.0226	CcSEcCtD
Trimipramine—Arrhythmia—Liothyronine—hypothyroidism	0.00822	0.0226	CcSEcCtD
Trimipramine—SLC6A3—nerve—hypothyroidism	0.00751	0.0497	CbGeAlD
Trimipramine—Disorientation—Levothyroxine—hypothyroidism	0.0073	0.0201	CcSEcCtD
Trimipramine—Disorientation—Dextrothyroxine—hypothyroidism	0.0073	0.0201	CcSEcCtD
Trimipramine—Hypertension—Liothyronine—hypothyroidism	0.00692	0.019	CcSEcCtD
Trimipramine—CYP2C9—urine—hypothyroidism	0.00641	0.0424	CbGeAlD
Trimipramine—Tachycardia—Liothyronine—hypothyroidism	0.00638	0.0175	CcSEcCtD
Trimipramine—Hypotension—Liothyronine—hypothyroidism	0.00611	0.0168	CcSEcCtD
Trimipramine—SLC6A2—nerve—hypothyroidism	0.00606	0.0401	CbGeAlD
Trimipramine—DRD2—nerve—hypothyroidism	0.00552	0.0366	CbGeAlD
Trimipramine—Disorientation—Liotrix—hypothyroidism	0.00537	0.0148	CcSEcCtD
Trimipramine—HTR2A—urine—hypothyroidism	0.00528	0.0349	CbGeAlD
Trimipramine—Body temperature increased—Liothyronine—hypothyroidism	0.00517	0.0142	CcSEcCtD
Trimipramine—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00496	0.0136	CcSEcCtD
Trimipramine—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00496	0.0136	CcSEcCtD
Trimipramine—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00494	0.0136	CcSEcCtD
Trimipramine—Myocardial infarction—Levothyroxine—hypothyroidism	0.00494	0.0136	CcSEcCtD
Trimipramine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00491	0.0135	CcSEcCtD
Trimipramine—CYP3A4—urine—hypothyroidism	0.00488	0.0323	CbGeAlD
Trimipramine—CYP2D6—urine—hypothyroidism	0.00481	0.0318	CbGeAlD
Trimipramine—Flushing—Dextrothyroxine—hypothyroidism	0.0042	0.0115	CcSEcCtD
Trimipramine—Flushing—Levothyroxine—hypothyroidism	0.0042	0.0115	CcSEcCtD
Trimipramine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00404	0.0111	CcSEcCtD
Trimipramine—Arrhythmia—Levothyroxine—hypothyroidism	0.00404	0.0111	CcSEcCtD
Trimipramine—Alopecia—Levothyroxine—hypothyroidism	0.00399	0.011	CcSEcCtD
Trimipramine—Alopecia—Dextrothyroxine—hypothyroidism	0.00399	0.011	CcSEcCtD
Trimipramine—Tremor—Dextrothyroxine—hypothyroidism	0.00369	0.0101	CcSEcCtD
Trimipramine—Tremor—Levothyroxine—hypothyroidism	0.00369	0.0101	CcSEcCtD
Trimipramine—Acute coronary syndrome—Liotrix—hypothyroidism	0.00365	0.01	CcSEcCtD
Trimipramine—HTR2A—nerve—hypothyroidism	0.00364	0.0241	CbGeAlD
Trimipramine—Myocardial infarction—Liotrix—hypothyroidism	0.00363	0.00998	CcSEcCtD
Trimipramine—Agitation—Dextrothyroxine—hypothyroidism	0.00362	0.00994	CcSEcCtD
Trimipramine—Agitation—Levothyroxine—hypothyroidism	0.00362	0.00994	CcSEcCtD
Trimipramine—Palpitations—Levothyroxine—hypothyroidism	0.00348	0.00956	CcSEcCtD
Trimipramine—Palpitations—Dextrothyroxine—hypothyroidism	0.00348	0.00956	CcSEcCtD
Trimipramine—Convulsion—Levothyroxine—hypothyroidism	0.00341	0.00937	CcSEcCtD
Trimipramine—Convulsion—Dextrothyroxine—hypothyroidism	0.00341	0.00937	CcSEcCtD
Trimipramine—Anxiety—Dextrothyroxine—hypothyroidism	0.00334	0.00917	CcSEcCtD
Trimipramine—Anxiety—Levothyroxine—hypothyroidism	0.00334	0.00917	CcSEcCtD
Trimipramine—Hypoaesthesia—Liotrix—hypothyroidism	0.00331	0.00909	CcSEcCtD
Trimipramine—Confusional state—Dextrothyroxine—hypothyroidism	0.00324	0.0089	CcSEcCtD
Trimipramine—Confusional state—Levothyroxine—hypothyroidism	0.00324	0.0089	CcSEcCtD
Trimipramine—Tachycardia—Levothyroxine—hypothyroidism	0.00313	0.00861	CcSEcCtD
Trimipramine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00313	0.00861	CcSEcCtD
Trimipramine—Flushing—Liotrix—hypothyroidism	0.00309	0.00848	CcSEcCtD
Trimipramine—Arrhythmia—Liotrix—hypothyroidism	0.00297	0.00816	CcSEcCtD
Trimipramine—Alopecia—Liotrix—hypothyroidism	0.00294	0.00807	CcSEcCtD
Trimipramine—Insomnia—Levothyroxine—hypothyroidism	0.0029	0.00798	CcSEcCtD
Trimipramine—Insomnia—Dextrothyroxine—hypothyroidism	0.0029	0.00798	CcSEcCtD
Trimipramine—Dysgeusia—Liotrix—hypothyroidism	0.00283	0.00779	CcSEcCtD
Trimipramine—Fatigue—Levothyroxine—hypothyroidism	0.00277	0.00761	CcSEcCtD
Trimipramine—Fatigue—Dextrothyroxine—hypothyroidism	0.00277	0.00761	CcSEcCtD
Trimipramine—Vision blurred—Liotrix—hypothyroidism	0.00273	0.0075	CcSEcCtD
Trimipramine—Tremor—Liotrix—hypothyroidism	0.00271	0.00745	CcSEcCtD
Trimipramine—Agitation—Liotrix—hypothyroidism	0.00266	0.00731	CcSEcCtD
Trimipramine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00265	0.00727	CcSEcCtD
Trimipramine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00265	0.00727	CcSEcCtD
Trimipramine—HTR1D—cardiovascular system—hypothyroidism	0.00257	0.017	CbGeAlD
Trimipramine—Palpitations—Liotrix—hypothyroidism	0.00256	0.00703	CcSEcCtD
Trimipramine—Urticaria—Dextrothyroxine—hypothyroidism	0.00255	0.00701	CcSEcCtD
Trimipramine—Urticaria—Levothyroxine—hypothyroidism	0.00255	0.00701	CcSEcCtD
Trimipramine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00254	0.00698	CcSEcCtD
Trimipramine—Abdominal pain—Levothyroxine—hypothyroidism	0.00254	0.00698	CcSEcCtD
Trimipramine—Body temperature increased—Levothyroxine—hypothyroidism	0.00254	0.00698	CcSEcCtD
Trimipramine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00254	0.00698	CcSEcCtD
Trimipramine—Convulsion—Liotrix—hypothyroidism	0.00251	0.00689	CcSEcCtD
Trimipramine—HTR3A—blood—hypothyroidism	0.0025	0.0166	CbGeAlD
Trimipramine—Hypertension—Liotrix—hypothyroidism	0.0025	0.00687	CcSEcCtD
Trimipramine—Anxiety—Liotrix—hypothyroidism	0.00246	0.00675	CcSEcCtD
Trimipramine—Confusional state—Liotrix—hypothyroidism	0.00238	0.00655	CcSEcCtD
Trimipramine—Oedema—Liotrix—hypothyroidism	0.00236	0.00649	CcSEcCtD
Trimipramine—Tachycardia—Liotrix—hypothyroidism	0.00231	0.00634	CcSEcCtD
Trimipramine—Asthenia—Dextrothyroxine—hypothyroidism	0.0023	0.00633	CcSEcCtD
Trimipramine—Asthenia—Levothyroxine—hypothyroidism	0.0023	0.00633	CcSEcCtD
Trimipramine—Pruritus—Dextrothyroxine—hypothyroidism	0.00227	0.00624	CcSEcCtD
Trimipramine—Pruritus—Levothyroxine—hypothyroidism	0.00227	0.00624	CcSEcCtD
Trimipramine—Anorexia—Liotrix—hypothyroidism	0.00225	0.00619	CcSEcCtD
Trimipramine—Hypotension—Liotrix—hypothyroidism	0.00221	0.00607	CcSEcCtD
Trimipramine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0022	0.00604	CcSEcCtD
Trimipramine—Diarrhoea—Levothyroxine—hypothyroidism	0.0022	0.00604	CcSEcCtD
Trimipramine—HTR1A—cardiovascular system—hypothyroidism	0.00214	0.0142	CbGeAlD
Trimipramine—Insomnia—Liotrix—hypothyroidism	0.00214	0.00587	CcSEcCtD
Trimipramine—Paraesthesia—Liotrix—hypothyroidism	0.00212	0.00583	CcSEcCtD
Trimipramine—ADRA1A—heart—hypothyroidism	0.00209	0.0138	CbGeAlD
Trimipramine—Decreased appetite—Liotrix—hypothyroidism	0.00205	0.00564	CcSEcCtD
Trimipramine—Vomiting—Levothyroxine—hypothyroidism	0.00204	0.00561	CcSEcCtD
Trimipramine—Vomiting—Dextrothyroxine—hypothyroidism	0.00204	0.00561	CcSEcCtD
Trimipramine—Fatigue—Liotrix—hypothyroidism	0.00204	0.0056	CcSEcCtD
Trimipramine—Rash—Levothyroxine—hypothyroidism	0.00203	0.00556	CcSEcCtD
Trimipramine—Rash—Dextrothyroxine—hypothyroidism	0.00203	0.00556	CcSEcCtD
Trimipramine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00202	0.00556	CcSEcCtD
Trimipramine—Dermatitis—Levothyroxine—hypothyroidism	0.00202	0.00556	CcSEcCtD
Trimipramine—Constipation—Liotrix—hypothyroidism	0.00202	0.00555	CcSEcCtD
Trimipramine—Headache—Levothyroxine—hypothyroidism	0.00201	0.00553	CcSEcCtD
Trimipramine—Headache—Dextrothyroxine—hypothyroidism	0.00201	0.00553	CcSEcCtD
Trimipramine—ADRA1A—cardiovascular system—hypothyroidism	0.00197	0.0131	CbGeAlD
Trimipramine—Feeling abnormal—Liotrix—hypothyroidism	0.00195	0.00535	CcSEcCtD
Trimipramine—SLC6A2—gonad—hypothyroidism	0.00193	0.0128	CbGeAlD
Trimipramine—Nausea—Dextrothyroxine—hypothyroidism	0.00191	0.00524	CcSEcCtD
Trimipramine—Nausea—Levothyroxine—hypothyroidism	0.00191	0.00524	CcSEcCtD
Trimipramine—SLC6A4—blood—hypothyroidism	0.00191	0.0126	CbGeAlD
Trimipramine—Urticaria—Liotrix—hypothyroidism	0.00188	0.00516	CcSEcCtD
Trimipramine—Abdominal pain—Liotrix—hypothyroidism	0.00187	0.00513	CcSEcCtD
Trimipramine—Body temperature increased—Liotrix—hypothyroidism	0.00187	0.00513	CcSEcCtD
Trimipramine—SLC6A3—testis—hypothyroidism	0.00172	0.0114	CbGeAlD
Trimipramine—DRD2—pituitary gland—hypothyroidism	0.00171	0.0113	CbGeAlD
Trimipramine—Asthenia—Liotrix—hypothyroidism	0.0017	0.00466	CcSEcCtD
Trimipramine—HTR1A—adrenal gland—hypothyroidism	0.00169	0.0112	CbGeAlD
Trimipramine—SLC6A2—adrenal gland—hypothyroidism	0.00168	0.0111	CbGeAlD
Trimipramine—Pruritus—Liotrix—hypothyroidism	0.00167	0.00459	CcSEcCtD
Trimipramine—CYP2C9—heart—hypothyroidism	0.00164	0.0109	CbGeAlD
Trimipramine—Diarrhoea—Liotrix—hypothyroidism	0.00162	0.00444	CcSEcCtD
Trimipramine—ADRA2A—heart—hypothyroidism	0.00159	0.0105	CbGeAlD
Trimipramine—SLC6A3—cerebellum—hypothyroidism	0.00159	0.0105	CbGeAlD
Trimipramine—CYP2C19—blood—hypothyroidism	0.00158	0.0105	CbGeAlD
Trimipramine—Dizziness—Liotrix—hypothyroidism	0.00156	0.00429	CcSEcCtD
Trimipramine—ADRA1A—adrenal gland—hypothyroidism	0.00156	0.0103	CbGeAlD
Trimipramine—ADRA1A—blood—hypothyroidism	0.00156	0.0103	CbGeAlD
Trimipramine—CYP2C9—cardiovascular system—hypothyroidism	0.00155	0.0103	CbGeAlD
Trimipramine—Vomiting—Liotrix—hypothyroidism	0.0015	0.00413	CcSEcCtD
Trimipramine—Rash—Liotrix—hypothyroidism	0.00149	0.00409	CcSEcCtD
Trimipramine—Dermatitis—Liotrix—hypothyroidism	0.00149	0.00409	CcSEcCtD
Trimipramine—Headache—Liotrix—hypothyroidism	0.00148	0.00407	CcSEcCtD
Trimipramine—Nausea—Liotrix—hypothyroidism	0.0014	0.00386	CcSEcCtD
Trimipramine—SLC6A2—testis—hypothyroidism	0.00139	0.00919	CbGeAlD
Trimipramine—ADRA2A—gonad—hypothyroidism	0.00136	0.00902	CbGeAlD
Trimipramine—HTR2A—heart—hypothyroidism	0.00135	0.00895	CbGeAlD
Trimipramine—ADRA2A—pituitary gland—hypothyroidism	0.00133	0.0088	CbGeAlD
Trimipramine—HTR1A—cerebellum—hypothyroidism	0.00129	0.00856	CbGeAlD
Trimipramine—HTR2A—cardiovascular system—hypothyroidism	0.00128	0.00845	CbGeAlD
Trimipramine—DRD2—testis—hypothyroidism	0.00126	0.00838	CbGeAlD
Trimipramine—CYP2C19—liver—hypothyroidism	0.00124	0.00818	CbGeAlD
Trimipramine—CYP2C9—blood—hypothyroidism	0.00122	0.00811	CbGeAlD
Trimipramine—ADRA1A—liver—hypothyroidism	0.00122	0.00808	CbGeAlD
Trimipramine—HRH1—adrenal gland—hypothyroidism	0.00121	0.008	CbGeAlD
Trimipramine—ADRA1A—cerebellum—hypothyroidism	0.00119	0.00789	CbGeAlD
Trimipramine—ADRA2A—adrenal gland—hypothyroidism	0.00119	0.00786	CbGeAlD
Trimipramine—ADRA2A—blood—hypothyroidism	0.00119	0.00786	CbGeAlD
Trimipramine—DRD2—cerebellum—hypothyroidism	0.00117	0.00774	CbGeAlD
Trimipramine—HTR2A—gonad—hypothyroidism	0.00116	0.00767	CbGeAlD
Trimipramine—ADRA2A—thyroid gland—hypothyroidism	0.00114	0.00758	CbGeAlD
Trimipramine—HTR2A—pituitary gland—hypothyroidism	0.00113	0.00748	CbGeAlD
Trimipramine—HRH1—female gonad—hypothyroidism	0.00113	0.00746	CbGeAlD
Trimipramine—ADRA2A—female gonad—hypothyroidism	0.00111	0.00733	CbGeAlD
Trimipramine—HTR2A—adrenal gland—hypothyroidism	0.00101	0.00668	CbGeAlD
Trimipramine—HTR2A—blood—hypothyroidism	0.00101	0.00668	CbGeAlD
Trimipramine—HRH1—testis—hypothyroidism	0.000999	0.00662	CbGeAlD
Trimipramine—ADRA2A—testis—hypothyroidism	0.000981	0.0065	CbGeAlD
Trimipramine—CYP2C9—liver—hypothyroidism	0.000958	0.00634	CbGeAlD
Trimipramine—CYP3A4—blood—hypothyroidism	0.000934	0.00618	CbGeAlD
Trimipramine—CYP2D6—blood—hypothyroidism	0.000919	0.00609	CbGeAlD
Trimipramine—ABCB1—adrenal cortex—hypothyroidism	0.000916	0.00607	CbGeAlD
Trimipramine—ADRA2A—cerebellum—hypothyroidism	0.000906	0.006	CbGeAlD
Trimipramine—ABCB1—heart—hypothyroidism	0.000886	0.00587	CbGeAlD
Trimipramine—CYP2D6—female gonad—hypothyroidism	0.000857	0.00568	CbGeAlD
Trimipramine—ABCB1—cardiovascular system—hypothyroidism	0.000836	0.00554	CbGeAlD
Trimipramine—HTR2A—testis—hypothyroidism	0.000834	0.00553	CbGeAlD
Trimipramine—HTR2A—liver—hypothyroidism	0.000789	0.00522	CbGeAlD
Trimipramine—HTR2A—cerebellum—hypothyroidism	0.000771	0.0051	CbGeAlD
Trimipramine—CYP2D6—testis—hypothyroidism	0.00076	0.00503	CbGeAlD
Trimipramine—ABCB1—gonad—hypothyroidism	0.000759	0.00502	CbGeAlD
Trimipramine—ABCB1—pituitary gland—hypothyroidism	0.00074	0.0049	CbGeAlD
Trimipramine—CYP3A4—liver—hypothyroidism	0.00073	0.00484	CbGeAlD
Trimipramine—CYP2D6—liver—hypothyroidism	0.000719	0.00476	CbGeAlD
Trimipramine—CYP2D6—cerebellum—hypothyroidism	0.000702	0.00465	CbGeAlD
Trimipramine—ABCB1—adrenal gland—hypothyroidism	0.000661	0.00438	CbGeAlD
Trimipramine—ABCB1—blood—hypothyroidism	0.000661	0.00438	CbGeAlD
Trimipramine—ABCB1—thyroid gland—hypothyroidism	0.000638	0.00422	CbGeAlD
Trimipramine—ABCB1—female gonad—hypothyroidism	0.000616	0.00408	CbGeAlD
Trimipramine—ABCB1—testis—hypothyroidism	0.000547	0.00362	CbGeAlD
Trimipramine—ABCB1—liver—hypothyroidism	0.000517	0.00342	CbGeAlD
Trimipramine—ABCB1—cerebellum—hypothyroidism	0.000505	0.00334	CbGeAlD
Trimipramine—CYP2C9—Metabolism—IYD—hypothyroidism	9.35e-05	0.00103	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—TRH—hypothyroidism	9.33e-05	0.00103	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	9.33e-05	0.00103	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	9.33e-05	0.00103	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	9.21e-05	0.00101	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—TSHB—hypothyroidism	9.19e-05	0.00101	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—TSHR—hypothyroidism	9.19e-05	0.00101	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	9.18e-05	0.00101	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	9.18e-05	0.00101	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	9.16e-05	0.00101	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	9.16e-05	0.00101	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	9.16e-05	0.00101	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	8.99e-05	0.000989	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	8.99e-05	0.000989	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ATP5O—hypothyroidism	8.72e-05	0.00096	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—VAV3—hypothyroidism	8.71e-05	0.000959	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	8.71e-05	0.000959	CbGpPWpGaD
Trimipramine—CYP2C19—Biological oxidations—POMC—hypothyroidism	8.69e-05	0.000957	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TRH—hypothyroidism	8.57e-05	0.000944	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ATP5O—hypothyroidism	8.51e-05	0.000937	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	8.51e-05	0.000937	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.49e-05	0.000935	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	8.47e-05	0.000933	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	8.47e-05	0.000933	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—AVP—hypothyroidism	8.39e-05	0.000924	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.35e-05	0.00092	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	8.35e-05	0.000919	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	8.35e-05	0.000919	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.34e-05	0.000918	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	8.34e-05	0.000918	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	8.34e-05	0.000918	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—TSHB—hypothyroidism	8.32e-05	0.000916	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—TSHR—hypothyroidism	8.32e-05	0.000916	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—TPO—hypothyroidism	8.2e-05	0.000903	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.18e-05	0.000901	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	8.16e-05	0.000899	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	8.16e-05	0.000899	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—VAV3—hypothyroidism	8.08e-05	0.00089	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ATP5O—hypothyroidism	8.02e-05	0.000883	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—TPO—hypothyroidism	8e-05	0.000881	CbGpPWpGaD
Trimipramine—CYP2D6—Biological oxidations—POMC—hypothyroidism	7.99e-05	0.00088	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ATP5O—hypothyroidism	7.95e-05	0.000875	CbGpPWpGaD
Trimipramine—CYP2C9—Biological oxidations—POMC—hypothyroidism	7.93e-05	0.000873	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—VAV3—hypothyroidism	7.91e-05	0.000871	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	7.66e-05	0.000844	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TSHB—hypothyroidism	7.64e-05	0.000841	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TSHR—hypothyroidism	7.64e-05	0.000841	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	7.63e-05	0.00084	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—AVP—hypothyroidism	7.62e-05	0.000839	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	7.6e-05	0.000837	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.6e-05	0.000836	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	7.58e-05	0.000835	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	7.58e-05	0.000835	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—TPO—hypothyroidism	7.54e-05	0.00083	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	7.5e-05	0.000826	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—TPO—hypothyroidism	7.48e-05	0.000823	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CLTC—hypothyroidism	7.4e-05	0.000815	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—POMC—hypothyroidism	7.36e-05	0.000811	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CLTC—hypothyroidism	7.36e-05	0.00081	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—POMC—hypothyroidism	7.33e-05	0.000806	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	7.05e-05	0.000776	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	7.01e-05	0.000772	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.93e-05	0.000763	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	6.81e-05	0.00075	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	6.73e-05	0.000741	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TRH—hypothyroidism	6.62e-05	0.000729	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—IGF1—hypothyroidism	6.56e-05	0.000722	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	6.5e-05	0.000716	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CLTC—hypothyroidism	6.5e-05	0.000715	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	6.49e-05	0.000714	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	6.47e-05	0.000712	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—POMC—hypothyroidism	6.47e-05	0.000712	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TRH—hypothyroidism	6.39e-05	0.000704	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	6.39e-05	0.000704	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CLTC—hypothyroidism	6.38e-05	0.000702	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TRH—hypothyroidism	6.36e-05	0.0007	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	6.36e-05	0.0007	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—POMC—hypothyroidism	6.35e-05	0.000699	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	6.26e-05	0.000689	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	6.26e-05	0.000689	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	6.23e-05	0.000686	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	6.23e-05	0.000686	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	6.19e-05	0.000681	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—IYD—hypothyroidism	6.17e-05	0.000679	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	6.11e-05	0.000673	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TRH—hypothyroidism	6.09e-05	0.00067	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	5.96e-05	0.000657	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.92e-05	0.000652	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	5.9e-05	0.00065	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	5.9e-05	0.00065	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	5.9e-05	0.00065	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	5.89e-05	0.000648	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	5.87e-05	0.000646	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	5.82e-05	0.00064	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	5.79e-05	0.000637	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	5.71e-05	0.000628	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TSHB—hypothyroidism	5.7e-05	0.000627	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TSHR—hypothyroidism	5.7e-05	0.000627	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AVP—hypothyroidism	5.69e-05	0.000626	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	5.67e-05	0.000624	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	5.67e-05	0.000624	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	5.66e-05	0.000623	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	5.62e-05	0.000619	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	5.61e-05	0.000618	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TRH—hypothyroidism	5.61e-05	0.000618	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	5.6e-05	0.000617	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	5.58e-05	0.000614	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TRH—hypothyroidism	5.52e-05	0.000608	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TRH—hypothyroidism	5.51e-05	0.000607	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	5.5e-05	0.000605	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	5.5e-05	0.000605	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	5.43e-05	0.000598	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	5.43e-05	0.000598	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	5.42e-05	0.000596	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	5.41e-05	0.000596	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TRH—hypothyroidism	5.41e-05	0.000596	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AVP—hypothyroidism	5.4e-05	0.000594	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—TSHB—hypothyroidism	5.36e-05	0.00059	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	5.3e-05	0.000583	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	5.26e-05	0.000579	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.24e-05	0.000577	CbGpPWpGaD
Trimipramine—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.23e-05	0.000575	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	5.18e-05	0.00057	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	5.11e-05	0.000562	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	5.1e-05	0.000561	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—VAV3—hypothyroidism	5.09e-05	0.00056	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	5.08e-05	0.000559	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—POMC—hypothyroidism	5.07e-05	0.000558	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	5.05e-05	0.000556	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PRL—hypothyroidism	5.05e-05	0.000556	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TRH—hypothyroidism	5.03e-05	0.000553	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TSHB—hypothyroidism	5e-05	0.000551	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TSHR—hypothyroidism	5e-05	0.000551	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	4.99e-05	0.00055	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AVP—hypothyroidism	4.99e-05	0.00055	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—IGF1—hypothyroidism	4.98e-05	0.000548	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TPO—hypothyroidism	4.93e-05	0.000543	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	4.92e-05	0.000542	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	4.92e-05	0.000542	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	4.92e-05	0.000542	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TSHR—hypothyroidism	4.91e-05	0.000541	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TSHB—hypothyroidism	4.91e-05	0.000541	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	4.91e-05	0.000541	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AVP—hypothyroidism	4.9e-05	0.00054	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	4.84e-05	0.000533	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	4.82e-05	0.000531	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	4.82e-05	0.000531	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	4.81e-05	0.00053	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	4.77e-05	0.000526	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VAV3—hypothyroidism	4.67e-05	0.000515	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.66e-05	0.000513	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	4.64e-05	0.000511	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AVP—hypothyroidism	4.5e-05	0.000496	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	4.48e-05	0.000493	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	4.48e-05	0.000493	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	4.47e-05	0.000492	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	4.46e-05	0.000491	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	4.39e-05	0.000483	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SH2B3—hypothyroidism	4.38e-05	0.000482	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	4.31e-05	0.000475	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	4.3e-05	0.000473	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	4.16e-05	0.000458	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	4.14e-05	0.000456	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—SLC5A5—hypothyroidism	4.01e-05	0.000442	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	3.99e-05	0.00044	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	3.96e-05	0.000436	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	3.91e-05	0.000431	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PRL—hypothyroidism	3.9e-05	0.00043	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—TSHB—hypothyroidism	3.8e-05	0.000418	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—POMC—hypothyroidism	3.78e-05	0.000416	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PRL—hypothyroidism	3.77e-05	0.000415	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	3.76e-05	0.000414	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PRL—hypothyroidism	3.75e-05	0.000413	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—TSHB—hypothyroidism	3.7e-05	0.000408	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	3.65e-05	0.000402	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	3.61e-05	0.000398	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	3.6e-05	0.000396	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	3.59e-05	0.000396	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PRL—hypothyroidism	3.59e-05	0.000395	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—POMC—hypothyroidism	3.59e-05	0.000395	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	3.52e-05	0.000388	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—TSHB—hypothyroidism	3.49e-05	0.000384	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VAV3—hypothyroidism	3.49e-05	0.000384	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AVP—hypothyroidism	3.48e-05	0.000383	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	3.47e-05	0.000382	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—TSHB—hypothyroidism	3.46e-05	0.000381	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	3.38e-05	0.000372	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AVP—hypothyroidism	3.36e-05	0.00037	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AVP—hypothyroidism	3.34e-05	0.000368	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.34e-05	0.000367	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	3.32e-05	0.000366	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—POMC—hypothyroidism	3.32e-05	0.000365	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PRL—hypothyroidism	3.31e-05	0.000364	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.3e-05	0.000364	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	3.27e-05	0.00036	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	3.26e-05	0.000359	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—POMC—hypothyroidism	3.26e-05	0.000359	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PRL—hypothyroidism	3.26e-05	0.000358	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PRL—hypothyroidism	3.25e-05	0.000358	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AVP—hypothyroidism	3.2e-05	0.000352	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	3.2e-05	0.000352	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PRL—hypothyroidism	3.19e-05	0.000351	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	3.11e-05	0.000343	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	3.08e-05	0.00034	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VAV3—hypothyroidism	3.06e-05	0.000337	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.04e-05	0.000335	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	3.01e-05	0.000332	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VAV3—hypothyroidism	3.01e-05	0.000331	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—POMC—hypothyroidism	2.99e-05	0.000329	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	2.97e-05	0.000327	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PRL—hypothyroidism	2.96e-05	0.000326	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	2.95e-05	0.000325	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AVP—hypothyroidism	2.95e-05	0.000325	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AVP—hypothyroidism	2.9e-05	0.000319	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AVP—hypothyroidism	2.9e-05	0.000319	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IGF1—hypothyroidism	2.88e-05	0.000317	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AVP—hypothyroidism	2.84e-05	0.000313	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.84e-05	0.000313	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.77e-05	0.000305	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	2.74e-05	0.000302	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AVP—hypothyroidism	2.64e-05	0.000291	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	2.61e-05	0.000288	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—SLC5A5—hypothyroidism	2.59e-05	0.000285	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—POMC—hypothyroidism	2.31e-05	0.000255	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TSHB—hypothyroidism	2.28e-05	0.000251	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—POMC—hypothyroidism	2.23e-05	0.000246	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	2.22e-05	0.000245	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—POMC—hypothyroidism	2.22e-05	0.000244	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IGF1—hypothyroidism	2.15e-05	0.000236	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	2.14e-05	0.000235	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—POMC—hypothyroidism	2.13e-05	0.000234	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—POMC—hypothyroidism	2.1e-05	0.000231	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	2.04e-05	0.000225	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.03e-05	0.000224	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—POMC—hypothyroidism	1.96e-05	0.000216	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—POMC—hypothyroidism	1.93e-05	0.000212	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—POMC—hypothyroidism	1.92e-05	0.000212	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—POMC—hypothyroidism	1.89e-05	0.000208	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.89e-05	0.000208	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	1.85e-05	0.000204	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IGF1—hypothyroidism	1.85e-05	0.000204	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	1.82e-05	0.0002	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.75e-05	0.000193	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.71e-05	0.000188	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	1.69e-05	0.000186	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—POMC—hypothyroidism	1.49e-05	0.000164	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—POMC—hypothyroidism	1.45e-05	0.00016	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—POMC—hypothyroidism	1.37e-05	0.000151	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—POMC—hypothyroidism	1.36e-05	0.000149	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—POMC—hypothyroidism	8.94e-06	9.84e-05	CbGpPWpGaD
